Treatment with non-selective beta-blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.


Por: Gimenez, P, Garcia-Martinez, I, Frances, R, Gonzalez J, Mauri M, Alfayate R, Almenara S, Miralles C, Palazon J, Carnicer F, Pascual, S, Such, J, Horga J and Zapater, P

Publicada: 1 dic 2018
Categoría: Hepatology

Resumen:
The use of non-selective beta-blockers has been associated with lower rates of infection and reduced infection-associated morbidity in patients with cirrhosis. However, it is unknown if these drugs modify the systemic inflammatory response to circulating bacterial DNA.

Filiaciones:
Gimenez, P:
 Inst Salud Carlos III, CIBERehd, Madrid, Spain

Garcia-Martinez, I:
 Inst Salud Carlos III, CIBERehd, Madrid, Spain

Frances, R:
 Inst Salud Carlos III, CIBERehd, Madrid, Spain

 Univ Miguel Hernandez, Dept Med Clin, Alicante, Spain

Gonzalez J:
 Inst Salud Carlos III, CIBERehd, Madrid, Spain

Mauri M:
 Hosp Gen Univ Alicante, Serv Anal Clin, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain

Alfayate R:
 Hosp Gen Univ Alicante, Serv Anal Clin, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain

Almenara S:
 Hosp Gen Univ Alicante, Unidad Farmacol Clin, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain

Miralles C:
 Hosp Gen Univ Alicante, Unidad Hepat, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain

Palazon J:
 Inst Salud Carlos III, CIBERehd, Madrid, Spain

 Univ Miguel Hernandez, Dept Med Clin, Alicante, Spain

 Hosp Gen Univ Alicante, Unidad Hepat, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain

Carnicer F:
 Hosp Gen Univ Alicante, Unidad Hepat, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain

Pascual, S:
 Inst Salud Carlos III, CIBERehd, Madrid, Spain

 Hosp Gen Univ Alicante, Unidad Hepat, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain

Such, J:
 Cleveland Clin Abu Dhabi, Digest Dis Inst, Abu Dhabi, U Arab Emirates

 Case Western Reserve Univ, Lerner Sch Med, Cleveland, OH 44106 USA

Horga J:
 Hosp Gen Univ Alicante, Unidad Farmacol Clin, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain

 Univ Miguel Hernandez, Inst Bioingn, Alicante, Spain

Zapater, P:
 Inst Salud Carlos III, CIBERehd, Madrid, Spain

 Hosp Gen Univ Alicante, Unidad Farmacol Clin, Inst Invest Sanitaria & Biomed Alicante ISABIAL, Fdn FISABIO, Alicante, Spain

 Univ Miguel Hernandez, Inst Bioingn, Alicante, Spain
ISSN: 14783223





LIVER INTERNATIONAL
Editorial
WILEY-BLACKWELL, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 38 Número: 12
Páginas: 2219-2227
WOS Id: 000451333800014
ID de PubMed: 29802788

MÉTRICAS